Search results for:
hyaluronidase/pertuzumab/trastuzumab
hyaluronidase/pertuzumab/trastuzumab
| Drug Name |
Form |
Strength |
Ambulatory Use Only |
Ambulatory Restrictions |
Inpatient Restrictions |
Non-Formulary |
| Phesgo |
SOLUTION, SUBCUTANEOUS |
30,000 units/1200 mg/600 mg / 15 mL and 20,000 units/600 mg/600 mg/10 mL |
|
|
|
|
Last updated: Mar. 5, 2024